Immucor Inc: Stock Rating Summary
 Immucor Inc, a mid-cap growth company in the health care sector, is expected to significantly outperform the market over the next six months with less than average risk. 10 is the best possible rating.
- Pro
- The StockScouter measure of relative price change and consistency is very high. Very positive
- The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Very positive for a medium- to large-sized company like BLUD
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
- Con
- Shares are being heavily sold by financial institutions. Neutral for a large company like BLUD
Learn more about the StockScouter rating system.
|
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that growth stocks will be neutral, mid-cap stocks will be neutral, and health care stocks will be neutral. More on market trends
advertisement
| Previous Ratings |
|---|
| 1 Month ago | 7 |
| 3 Months ago | 10 |
| 6 Months ago | N/A |
|
Page generated 11/24/2009 10:35 PM Eastern Time
Recent News
